Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4770265 | 0.83 | THRA (0.44) | MAOBFFAR4MAOA | |
| SCHEMBL759938 | 0.80 | CES2 (0.37) | MAOB | |
| SCHEMBL28005957 | 0.78 | CES2 (0.36) | — | |
| SCHEMBL16080741 | 0.78 | MAOB (0.41) | MAOBMAPTFFAR4 | |
| SCHEMBL17806151 | 0.77 | MAOB (0.43) | MAOBMAPTFFAR1FFAR4MAOA | |
| SCHEMBL16211061 | 0.75 | FFAR4 (0.34) | MAOBFFAR4 | |
| SCHEMBL19703009 | 0.74 | MAOB (0.45) | MAOBMAPTFFAR1FFAR4MAOA | |
| SCHEMBL16210471 | 0.74 | SENP8 (0.40) | MAOBFFAR1FFAR4MAOA | |
| SCHEMBL19703013 | 0.71 | MAOB (0.43) | MAOBMAPTFFAR4 | |
| SCHEMBL31268450 | 0.70 | CES2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9573923-B2 | Liquid crystal compound having 2, 6-difluorophenylether structure, and liquid crystal composition containing the same | DIC CORPORATION (JP) | 2017-02-21 | — | — | US | disclosed |
| US-20160159765-A1 | LIQUID CRYSTAL COMPOUND HAVING 2, 6-DIFLUOROPHENYLETHER STRUCTURE, AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME | DIC CORPORATION (JP) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159765-A1 | LIQUID CRYSTAL COMPOUND HAVING 2, 6-DIFLUOROPHENYLETHER STRUCTURE, AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME | FGFR2, FGFR1, FGF2 | MAOB 3043/4885MAPT 92/4885FFAR1 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.